A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia
Authors
Keywords
-
Journal
Trials
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-08
DOI
10.1186/s13063-020-04971-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement
- (2020) Sarah P. Blagden et al. BRITISH JOURNAL OF CANCER
- Designs for adding a treatment arm to an ongoing clinical trial
- (2020) Maxine Bennett et al. Trials
- Including non-concurrent control patients in the analysis of platform trials: is it worth it?
- (2020) Kim May Lee et al. BMC Medical Research Methodology
- Mind the gap? The platform trial as a working environment
- (2019) Liz Morrell et al. Trials
- This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
- (2019) Francesca Schiavone et al. Trials
- Changing platforms without stopping the train: experiences of data management and data management systems when adapting platform protocols by adding and closing comparisons
- (2019) Dominic Hague et al. Trials
- Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study
- (2019) Peter Hillmen et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive platform trials: definition, design, conduct and reporting considerations
- (2019) NATURE REVIEWS DRUG DISCOVERY
- Avoiding bias in trials in which allocation ratio is varied
- (2018) Douglas G Altman JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Randomized trial of ibrutinib versus ibrutinib plus rituximab in patients with chronic lymphocytic leukemia
- (2018) Jan A. Burger et al. BLOOD
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial
- (2017) Laura Collett et al. Trials
- Recommendations on multiple testing adjustment in multi-arm trials with a shared control group
- (2016) Dena R Howard et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- The Platform Trial
- (2015) Scott M. Berry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study
- (2015) A C Rawstron et al. LEUKEMIA
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice
- (2015) Dena R Cohen et al. Trials
- Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
- (2012) Matthew R Sydes et al. Trials
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Multi-Arm Clinical Trials of New Agents: Some Design Considerations
- (2008) B. Freidlin et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now